Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.09 | 41.60 |
PEG Ratio (TTM) | 0.00 | 6.56 |
P/S Ratio (TTM) | 1.31 | 4.12 |
P/B Ratio (TTM) | 0.07 | 4.10 |
P/FCF Ratio (TTM) | -4.90 | 31.45 |
Price to 5YR AVG Earnings Ratio | N/A | 70.39 |
Price to 5YR AVG FCF Ratio | N/A | 45.08 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -68.62% | 3.90% |
ROE (TTM) | -26.38% | 14.91% |
Net Profit Margin (TTM) | -21.01% | 10.66% |
ROIC 5YR AVG | N/A | 13.31% |
Growth (58%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 27.79% | 960.29% | N/A |
Revenue | 141.86% | 101.68% | N/A |
Net Income | 19.56% | 44.95% | N/A |
Cash Flow | -55.82% | 120.21% | N/A |
Health (63%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 8.83 | 2.16 |
Quick Ratio (TTM) | 8.75 | 1.45 |
D/E Ratio (TTM) | 0.04 | 0.55 |
Interest Coverage (TTM) | 57.29 | 8.43 |
Piotroski F-Score | 2 | 6 |
Altman Z-Score | 21.90 | 5.16 |
LTL to 5YR AVG FCF | N/A | 5.03 |
Shares Outstanding Growth 5YR AVG | N/A | 5.28% |